Agree... nothing to do but chuckle a little and shake my head. Waited over ten years... the majority of the wait is certainly behind me. I guess that's why its a only a few who are there to finally catch the perfect wave. At least I hope!
Yeah... Just like they were crooks in giving Bar Or options at $6.48 - so they could screw everyone -- yeah right! Guess you owe some apologies don't you?
AAVL is supported by Venrock and Regeneron. Their market cap is less double that of AMPE -- probably the equivalent of about $12/share, but I haven't done the simple math. Can't help but agree that AMPE is undervalued (regardless of whether AAVL is properly valued or not). However, having Venrock and REGN behind you has some real benefits from a market standpoint, which benefits are lacking in the case of AMPE.
This may fall into the "hopium" category: Perhaps the company is trying to break the typical cycle of good news being unrewarded due to an apparent lack of notice. Through these releases the idea is that people will be paying a little more attention to AMPE so that their "big kahuna" (STEP results) will garner more attention than others have had. Who knows?
dovsafiir ... pretty amazing how someone who yesterday said "I'm pretty new at this" and needed help to understand the company's latest press release - now has a lock on a company's value - and can readily tell assess the accuracy or weight that should be given to someone else's opinion. You learn fast --- or maybe BS is a word you are most familiar with.
oh, brother(oday)!.... I sure hope you are right. I dream of it... and it happening soon (doubtful).
Your analysis obviously does not take into account any news. Based on positive STEP results we will see $8.50 within minutes, not hours, days, weeks or months. If good STEP results come out this week, we will be into double digits easily within minutes.
Wrong... Their employment agreements expire in August... just like they did last August, and also got an option award last August on renewal. They only acted on the agreements that expired and needed to be renewed this month.
I would very much doubt management would go for anything less than $30, and more likely something north of $40. Pure conjecture.
I don't think I've ever known Ampio to issue press releases on three straight business days. Not sure what to make of it other than that they have had three things in a row to report.
187 2-ply sheets. However, the question (the one on Celebrex) is not really inapplicable. Although Celebrex is most likely marketed to the less severe cases (1 & 2), i am sure they have a fair share of the 3s and 4s. Especially with HLA not being reimbursed.
Not only that, if they have any kind of non-publicly disclosed information, it would preclude them from trading, or be subject to insider trading issues. As a result, there are usually very small windows of opportunity for insiders to trade. I am sure there very many important pieces of information officers of AMPE have that is not publicly known.
dovsafir... its not an easy answer. Obviously, these were not the STEP results. They should be coming soon. The results today were the interim results of a multiple dosing trial of the same drug. The results were tremendous! However, due to the very limited number of participants, the fact that this initial part of the test was to test for safety (not effectiveness), the fact that the results are from an open study where there was no control administered, etc. etc. it doesn't hold a lot weight relative to the effectiveness, or improvement of effectiveness for multiple injections.
It does however, add more of what more than anecdotal evidence of the effectiveness of the drug itself, and gives a hint of what may be expected of the STEP results. Those of us that are sold on the drug, take this as just one more sign that Ampion is a miracle drug. It will;l take time to prove it, but this is a good positive step, as will be the results of the STEP trial (assuming they're positive). An important element to todays report is the anecdotal comments of the lead investigator, that this is like nothing they have ever seen before, and that it will change the way OAK is treated. Certainly it may be saline... but somehow I have to believe that multiple saline shots have been tried before, that the lead investigator is aware of that, and that the results from Ampion are significantly better/strong/etc.
Hope this helps rather than confuses.
Certainly possible... like they say "Just because you're paranoid, doesn't mean they are NOT out to get you!"
However, I believe they are reporting results and news as they get it. To do otherwise may be problematic. these top line results on the multiple injections is pretty easy to tabulate. MRI data and the like, and all of the other data required and sufficient for a successful BLA filing takes much more time and they need to be much more careful. I still think the data will come out this week.
I would think that the window within which Dr. Bar Or, or any other "insider" at Ampio, can sell their shares is pretty narrow. And I am confident that window is currently, and firmly, shut.
Alwaysaskwhy... interesting name.
You are correct in your analysis of the options and how they work, and that it is a very common practice.
You are 100% wrong in your last paragraph. These guys take, and have taken very, very, very little compensation out of this company. By far the vast majority of their comp is based upon the shareholders making money. And despite all kinds of bashing and fear mongering, none of them have sold a single share. As for the timing of these options, read my last post, as well as the company's filings. Nothing fishy at all.
Your comments - and their easily verifiable inaccuracies --- make-me-ask-why.
hubby... he has the OPTION to purchase 300,000 shares for $6.48 at any time over the next ten years. Right now he can only purchase 150,000 shares; after another year at the company his right to purchase an additional 150,000 shares "vests." So assuming they stay at the company for another year and all 300,000 options are "vested" he can exercise those options at any time before August 2024. You are correct. It makes no sense at all for him to exercise these options and purchase the stock at this time. It usually makes no sense to exercise qualified options like these are, unless you are also going to sell at the same time - except for old Uncle Sam. If he does exercise - buys the stock - and holds for a year he can get long term capital gains treatment. Its riskier, but you save 20% in taxes.
Check their SEC filings. The latest being their proxy statement. In that, under executive compensation, it details how their employment agreements dated August 2010 expired in 2013 and they were granted options as part of a one year extension. Now in 2014, they were again granted options for another one year extension.